caprolactone has been researched along with Spinal Cord Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doser, M; Kingham, PJ; Kolar, MK; Müller, E; Novikov, LN; Novikova, LN; Oberhoffner, S; Renardy, M; Ullrich, A; Wiberg, M | 1 |
| Ai, J; Babaloo, H; Kouhsari, SM; Terraf, P | 1 |
2 other study(ies) available for caprolactone and Spinal Cord Injuries
| Article | Year |
|---|---|
Trimethylene carbonate-caprolactone conduit with poly-p-dioxanone microfilaments to promote regeneration after spinal cord injury.
Topics: Animals; Astrocytes; Biocompatible Materials; Caproates; Cell Adhesion; Dioxanes; Female; Fibroblasts; Ganglia, Spinal; Glial Fibrillary Acidic Protein; Lactones; Nerve Regeneration; Neurites; Polymers; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Injuries; Tissue Scaffolds | 2018 |
Tissue-Engineered Regeneration of Hemisected Spinal Cord Using Human Endometrial Stem Cells, Poly ε-Caprolactone Scaffolds, and Crocin as a Neuroprotective Agent.
Topics: Animals; Caproates; Cell Culture Techniques; Humans; Lactones; Male; Nerve Regeneration; Neural Stem Cells; Neuroprotective Agents; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Tissue Scaffolds; Tumor Necrosis Factor-alpha | 2017 |